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disease. Limited long-term data, however, is available on long DES.
The prospective RESOLUTE 38-mm substudy of the RESOLUTE
Global Clinical Program enrolled patients requiring treatment of
de novo lesions in native coronary arteries with a 38-mm length
ResoluteTM DES (Santa Rosa, CA, Medtronic, PLC).
Methods: The RESOLUTE 38-mm substudy includes the RESOLUTE
US and RESOLUTE Asia prospective, observational, nonrando-
mized,multicenter trials that enrolled patients from29 sites across
theUnited States (U.S.) and 17 sites across Asia. Patients enrolled in
both studies who received at least one 38-mm Resolute DES in a
lesion ≤35 mm in length and reference vessel diameter of 3.0–
4.2 mm were included in the 38-mm substudy. Up to two lesions
(in separate vessels) could be treated.
Results and conclusion: A total of 223 patients (114 in RESOLUTEUS
and 109 in RESOLUTEAsia)were enrolled. Average agewas 61 years
old, 38% had diabetes mellitus, 54% had double or triple vessel
disease, and 32% had prior myocardial infarction. Most (91%)
treated lesions were American Heart Association Class B2/C, total
stent length per patient was 44.6  14.3 mm, and reference vessel
diameter 2.8  0.4 mm. Three-year follow-up in 221 (99.1%)
patients has been previously presented: target lesion failure
(TVF) was 10.4% and comprised of 2.3% cardiac death (CD), 5.4%
target vessel myocardial infarction (TV-MI), and 4.1% target lesion
revascularization (TLR). The incidence of deﬁnite and probable
stent thrombosis (ST; Academic Research Consortium deﬁnition)
was 0.9% at 3 years. There was furthermore no difference at 3 years
between RESOLUTEAsia andRESOLUTEUS in the rates of TLR (1.9%
vs. 6.2%, p = 0.172), CD (0.9% vs. 3.5%, p = 0.370), TV-MI (4.6% vs.
6.2%, p = 0.769), or ST (0.9% vs. 1.8%, p > 0.999); however, TLF (5.6%
vs. 15.0%, p = 0.027) was lower in RESOLUTE Asia. The prespeciﬁed
analysis of RESOLUTE 38 mm substudy conﬁrmed the safety and
efﬁcacy of the 38 mm length Resolute DES at three years with no
observed increased risk for restenosis (TLR 4.1%) or stent throm-
bosis (0.9%) despite the longer stent length. Long-term outcomes at
four years will be available at Cardiological Society of India 2015 to
evaluate whether these low clinical adverse events with the 38-
mm length Resolute DES were sustained.
Left main coronary artery disease – A
glorified indication of PCI
Rakesh Kumar Maurya *, Sanjeev Sanghvi
MDM Hospital, Dr. S.N. Medical College, Room No.77, New PG Hostel,
Jodhpur, Rajasthan, India
Introduction: Left main coronary artery (LMCA) stenosis is con-
sidered an attractive target for balloon angioplasty because of the
vessel's large caliber, the lack of tortuosity, and the short lesion
length. Histologically, the LMCA has the most elastic tissue of the
coronary vessels, accounting for the poor response of the LMCA to
simple balloon angioplasty. However, coronary stents have been
shown to reduce the immediate need for coronary artery bypass
surgery (CABG) for abrupt vessel closure and likelihood of rest-
enosis after balloon angioplasty. Stenting of unprotected LMCA
stenosis is therefore considered a therapeutic option in selected
patients.
Case report: A 65-year-oldmale presented to uswith complaints of
chest pain, anxiety, and sweating. On examination, his pulse was
106 per minute, blood pressure was 110/80 mmHg, and chest was
clear. Other physical examinations were normal. ECG showed ST
segment depression in all leads except aVR lead, which showed
elevation. He was planned for coronary angiography.
His coronary angiography showed 90% stenosis of LMCA and 60%
stenosis of LCX. He was planned for angioplasty and stenting to
LMCA. A XB 3.5 6F guiding catheter was used. Two balancedmiddle
weight (BMW) coronary wires were put in left anterior descending
artery and left circumﬂex artery. Lesion was predialated with
noncompliant balloon size 3.5 mm  10 mm at the pressure of
15 atm. Coronary stent size 4 mm  18 mm was deployed at the
pressure of 10 atm. Post-dilatation was done with noncompliant
balloon size 4 mm  10 mm at the pressure of 18 atm. Final result
was good and there was no residual stenosis and dissection.
Patient was stable and pain free after the procedure.
Implication to clinical practice: Coronary artery bypass surgery is
considered as the gold standard treatment of unprotected LMCA
disease. Over the last 20 years, improvement in stent technology
and operators experience explained the increased number of
reports on the result of percutaneous intervention for treatment
of LMCA lesion. Recent data comparing efﬁcacy and safety of PCIs
using drug eluting stents and coronary artery bypass surgery
showed comparable results in terms of safety and a lower need
of repeat revascularization procedure.
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Intravascular foreign bodies which are retained are a complication
of percutaneous procedures. Recently percutaneous retrieval of
intravascular foreign bodies has become a frequently used tech-
nique. Various intravascular foreign bodies include fragments of
central venous catheters (most common), knotted pulmonary
artery (Swan Ganz) catheters, lost guidewires or guidewire frag-
ments, misplaced embolization coils and metallic stents.
We present 3 cases of retrieval of devices from percutaneous
intervention.
 Retrieval of Innove wire,
 Retrieval of central venous catheter wire,
 Retrievel of central venous catheter.
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Background: In the last two decades, percutaneous techniques to
close cardiac defects have been developed. Owing to anatomical
relationship of conduction system and perimembranous ventri-
cular septal defect (PMVSD) location, there are reports of high
incidence of conduction disturbances and aortic regurgitation after
device closure. We aimed to evaluate the safety and efﬁcacy of
transcatheter device closure of PMVSDwith Amplatzer Duct Occlu-
der I (ADO) with special emphasis on conduction disturbance. ADO
I has no RV disc and long waist in comparison with other devices
and thus thought to produce less compression of surrounding
tissue and producing less conduction disturbances.
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Aims and objective: Evaluation of safety and efﬁcacy of transcath-
eter closure of PMVSD using ADO a mid-term follow up.
Material and methods: Between September 2012 and September
2015, 150 patients underwent percutaneous PMVSD device closure
with ADO at our institution. All patient underwent clinical exam-
ination, ECG, 2D echo and TEE pre-procedure, post procedure, 1, 3,
and at 6 months follow-up. Oral steroids were given to all the
patients for 5 days or long in those with conduction disturbances
and dose was tapered over 2–3 week period.
Results: Transcatheter closure of PMVSD was attempted in 150
patients, which was successful in 150 patients (100%). There were
85 male and 65 female patients. According to color Doppler TTE
before intervention, the average end-diastolic PMVSD size was
5.24 mm. Majority (81.02%) had no residual shunt at follow-up.
Total rhythm disturbances were seen in about 6.9% (11/158) of
patients with transient junctional rhythm occurring in 9 patients
and intermittent Mobitz type I 2:1 AV block in 2 patients. In our
study, all patient were given oral steroids in post procedure period
which was continued for 1 month in these patients who experi-
enced rhythm disturbances. None of the patient developed com-
plete AV block requiring temporary or permanent pacemaker.
Conclusion: In our study of percutaneous closure of PMVSD with
the ADO incidence of high grade AV conduction disturbances is
rare and transient. The use of oral steroids over a short-termperiod
can drastically reduce the incidence of conduction disturbances.
Percutaneous closure of PMVSD with ADO can be a safe, effective,
cheap and promising option.
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Background: The elderly constitute a rapidly expanding segment of
our population and CVD becomes more prevalent with increasing
age. Evidence suggests that the proportion of patients who receive
standard secondary prevention or revascularization declines as
they age beyond the eighth decade. High incidence of complica-
tions may be due to the high prevalence of associated comorbid-
ities and late referral for revascularization. The aim of the present
study was to assess clinical characteristics, procedural details, and
intermediate term outcomes in the patients older than 80 under-
going PCI.
Method: This was a single center, randomized prospective study.
Patients equal to or above the age of 80 years (Octogenarians) both
male and female presented with symptoms and signs of acute
coronary syndrome or chronic stable angina, and planned for
percutaneous coronary intervention were included in the study.
Parameters were assessed at baseline, pre-discharge and at 6
months post-procedure. MACE (Cardiac death, non-fatal MI,
CVA, stent thrombosis, bleeding and target vessel revasculariza-
tion) was taken as primary composite end point.
Result: Patients (n = 50) were divided into 2 groups: Group I (80–85
years, n = 35, 70%) and Group II (≥85 years, n = 15, 30%). At baseline,
overall presentation with STEMI, cardiogenic shock and heart
failure were signiﬁcantly more in group II compared to group I
{53.33% GpII vs 31.42% GpI ( p < 0.001), 26.67% GpII vs 8.57% GpI
( p < 0.001), 80% GpII vs 45.71% GpI ( p < 0.001), respectively}. Inci-
dence of double and triple vessel disease were more in Group II
than in Group I {93.33% GpII vs 82.85% GpI ( p < 0.001)}. Procedural
success was signiﬁcantly decreased in Group II {94.28% GpI vs
86.67% in GpII ( p < 0.001)}. Bleeding complications signiﬁcantly
increased in Group II {46.67% GpII vs 20% GpI ( p < 0.001)}. On 6
monthly follow-up, the overall (n = 50) all-causemortalitywas 24%,
MI incidence 8% and TVR 6%. MACE were signiﬁcantly increased in
Group II {46.67% GpII vs 17.14% GpI ( p < 0.001)}.
Conclusion: PCI and stenting can be done in elderly patients (>80
years) with reasonably high success and acceptable complication
rates. Within the group, the more elderly (>85 years) have higher
risk proﬁle, lesser success and higher complications and MACE.
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Introduction: Persistent left superior vena cava (PLSVC) with
absent right SVC is a rare congenital anomaly of the vena cava,
which poses challenges during performing transvenous pacing.
We report a case of a successful biventricular pacing and deﬁbril-
lator device implantation (CRT-D) via a persistent left superior
vena in a patient with dilated cardiomyopathy and severe LV
systolic dysfunction with absent right SVC.
Case report: A 53-yr-old male patient presented to us with sudden
onset of breathlessness with orthopnea. On evaluation ECG done
showed LBBB with QRS duration of 120 ms with secondary ST-T
changes. 2D Echo done showed dilated LVwith global hypokinesia,
ventricular dyssynchrony and severe LV systolic dysfunction with
2D LVEF 15–20%. Patient was treated conservatively and later
advised coronary angiography (CAG). CAG done showed non-
obstructive coronary artery disease. Patient was later discharged
on diuretics, ACE inhibitors, spiranolactone and beta blockers.
Despite being on optimal medical therapy for 3 months patient
remained in NYHA class II, hence CRT-D implantation was
planned.
Venography done revealed a PLSVC with absent right SVC with
PLSVC draining into an extremely dilated coronary sinus. A 5 F
Judkins-type angiographic catheter (JR 4.0) was used to perform
selective coronary sinus tributaries venography via the left sub-
clavian vein. Then with the help of guide wire lateral vein was
cannulated. Retaining the wire, the angiographic catheter was
replaced with a guiding sheath, and then the left ventricular lead
successfully positioned in a lateral vein. A dual-coil active-ﬁxation
deﬁbrillator lead was positioned in the right ventricular apex,
followed by a SonR active ﬁxation lead in the right atrial free wall.
All three leads were implanted through the PLSVC. Acute thresh-
olds were checked and all leads were eventually connected to a
CRT -D device. Later ECG done showed biventricular pacing and
chest X-ray done conﬁrmed the lead positions. The patient was
discharged from the hospital without complications.
Discussion: Persistent left SVC (PLSVC) is a rare anomaly of the
venous circulation, and it occurs in 0.5% of the general population,
0.3% of healthy persons, and 4.3% of those with congenital heart
disease. In most patients with left SVC, a right SVC is present. PL
SVC with absent right SVC occurs in only 0.09–0.13% of patients
who have congenital heart defects. Although this rare condition is
frequently associated with situs inversus, our patient was situs
solitus and lacked a right SVC and had a persistent left SVC that
drained into the right atrium via an extremely dilated coronary
sinus. This condition is typically asymptomatic, usually inciden-
tally discovered during pacemaker implantation and it can com-
plicate lead placement through the subclavian approach. Although
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